New Investor

Your are interested in Bayer as a new investor? On this page you find helpful links to information on the company and our shares, latest financial reports and key figures, news and events, corporate governance, sustainability and services for investors.

New Investor

Highlights


Restatements 2015 / 2016 due to New Regional Reporting Structure

Restatements 2015 / 2016 due to New Regional Reporting Structure

Reporting of the regions has been adjusted to reflect the distribution of responsibilities on the Board of Management.
Sales for Africa/Middle East are now no longer reported together with Latin America but with Europe.

Restated sales figures for 2015 and 2016Download (XLSX, 603 KB) collect


Publication of Full Year and Fourth Quarter 2016 results

Publication of Full Year and Fourth Quarter 2016 results

On the occasion of the publication of our Full Year and Fourth Quarter Quarter 2016 results we will host a conference call for investors and analysts on February 22, 2017 from approx. 2:00 p.m. CET.


Inside Information according to Article 17 MAR

Inside Information according to Article 17 MAR

Bayer: Phase III COMPASS study with Bayer’s Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint Early

Download (PDF, 66 KB) collect


Q4 2016 Consensus Estimates

Q4 2016 Consensus Estimates

The company is covered by various German and international financial analysts.

The analyst consensus for Q4 2016 is given here.


Q3 2016 All in One Package for Investors and Analysts

Q3 2016 All in One Package for Investors and Analysts

Service for Investors and Analysts:
Download all documents on our Third Quarter 2016 results in one ZIP file:

Download (ZIP, 5 MB) collect


Meet Management 2016

Meet Management 2016

Investor Conference Call: Bayer to Acquire Monsanto

Investor Conference Call: Bayer to Acquire Monsanto

Media conference call

Last updated: February 15, 2017 Copyright © Bayer AG